title: Impact of serum parathyroid hormone concentration and its regulatory factors on arterial stiffness in patients undergoing maintenance hemodialysis.
abstract: BACKGROUND
  Cardiovascular mortality is extremely high in patients on hemodialysis. Among a variety of pathophysiological conditions, deranged calcium homeostasis including secondary hyperparathyroidism may be one of the factors contributing to cardiovascular disease in patients on hemodialysis. This study was designed to evaluate the role of the serum parathyroid hormone (PTH) concentration and its regulatory factors in serum on arterial stiffness in patients on maintenance hemodialysis.
  
  
  METHODS
  Arterial stiffness was assessed by pulse wave velocity (PWV) in 73 non-diabetic patients undergoing maintenance hemodialysis. At the same time, serum concentrations of calcium, phosphate, and intact PTH were measured.
  
  
  RESULTS
  Single regression analyses revealed that arterial PWV was positively correlated with age (r = 0.505, p < 0.0001), systolic blood pressure (r = 0.250, p = 0.043), and pulse pressure (r = 0.306, p = 0.012). It was inversely correlated with the serum phosphate concentration (r = -0.240, p = 0.041) and the duration of hemodialysis treatment (r = -0.343, p = 0.003), but not with serum concentrations of calcium and intact PTH or the calcium x phosphate product in serum. By multiple regression analysis age was found to be the most significant variable affecting arterial PWV, and the duration of hemodialysis treatment negatively influenced arterial PWV.
  
  
  CONCLUSIONS
  Age is an independent risk factor for arterial stiffness in patients on maintenance hemodialysis, and the serum PTH concentration and its regulatory factors in the serum are not.
authors.affiliation: Department of Medicine, Fujinomiya City Hospital, Fujinomiya, Japan.
authors.forename: Takayuki
authors.initials: T
authors.lastname: Suzuki
authors.forename: Katsuhiko
authors.initials: K
authors.lastname: Yonemura
authors.forename: Yukitaka
authors.initials: Y
authors.lastname: Maruyama
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Takahashi
authors.forename: Takako
authors.initials: T
authors.lastname: Takita
authors.forename: Mitsuyoshi
authors.initials: M
authors.lastname: Furuhashi
authors.forename: Akira
authors.initials: A
authors.lastname: Hishida
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000209:etiology; D005260:Female; D006801:Humans; D006962:Hyperparathyroidism, Secondary; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood*; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors; D014157:Transcription Factors; D014655:Vascular Resistance
chemical_list: D010281:Parathyroid Hormone; D014157:Transcription Factors